Maryland Heights, MO, February 03, 2017 --(PR.com
)-- The global continuous glucose monitoring market is estimated to reach USD 1.2 Billion in 2020, expanding at a CAGR of 16.1% from 2016 to 2020, due to rising diabetes population worldwide.
Browse Continuous Glucose Monitoring Market by Device Type (Guardian Real Time CGM System, Freestyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, Minimed Paradigm Revel, Veo System) 2016-2020 at https://www.ihealthcareanalyst.com/report/continuous-glucose-monitoring-market/.
Continuous glucose monitoring (CGM) is a way to measure glucose levels in real-time throughout the day and night. It consists of small wearable device that tracks blood glucose, notifying the highs and lows in order to take better treatment decisions and better glucose control. A tiny electrode called a glucose sensor is inserted under the skin to measure glucose levels in tissue fluid. It is connected to a transmitter that sends the information via wireless radio frequency to a monitoring and display device. Continuous glucose monitoring systems are identified as one of the most important emerging tools for diabetes management, especially Type I diabetes in which patients are completely insulin dependent. CGM also helps to minimize the guesswork that comes from making decisions based solely on a number from a blood glucose meter reading, for better diabetes management.
The global continuous glucose monitoring market segmentation is based on product types (Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel, Veo System).
The global continuous glucose monitoring market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020). The global continuous glucose monitoring market research report is further segmented by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global continuous glucose monitoring market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global continuous glucose monitoring market and included in this report are Abbott Laboratories, Inc., Bayer AG, Dexcom, Inc., GlySens, Incorporated, Insulet Corporation, Medtronic, Inc., Nova Biomedical Corporation, and Senseonics, Incorporated.
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/continuous-glucose-monitoring-market/.
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043